Analyst Expectations for Karuna Therapeutics's Future
Portfolio Pulse from Benzinga Insights
Analysts have given Karuna Therapeutics (NASDAQ:KRTX) mostly bullish ratings, with an average price target of $256.38, indicating potential upside from the current price of $185.065. However, this average has decreased by 7.36% from the previous target of $276.75.
September 08, 2023 | 5:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Karuna Therapeutics has received mostly bullish ratings from analysts, indicating potential upside.
The bullish ratings from analysts indicate a positive outlook for Karuna Therapeutics. The average price target suggests potential upside from the current price, which could lead to an increase in the stock price in the short term. However, the decrease in the average price target could indicate some caution.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100